Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Turnaround Potential
1209.5000 -1.90 (-0.16%)
NSE Dec 26, 2025 12:06 PM
Volume: 118.9K
 

logo
Aurobindo Pharma Ltd.
06 Jun 2016
1209.50
-0.16%
Economic Times
The company paid its CEO, M Govindarajan, an average annual compensation of Rs 9.5 crore, which is above the average CEO salary during the period.
Aurobindo Pharma Ltd. is trading above all available SMAs
Aurobindo Pharma gets best value from payout to CEO in 3 years
Economic Times | 06 Jun 2016
More from Aurobindo Pharma Ltd.
Recommended
Market trades lower, Gujarat govt appoints Avantika Singh Aulakh as MD of Gujarat Gas
Trendlyne Marketwatch | 26 Dec 2025, 12:03PM
Nifty 50 in 2025: A market hit by policy and trade pressures
The Baseline | 24 Dec 2025, 06:56PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020